Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)


Phase 4 Results

Summary of Purpose

The KYOTO HEART Study is to assess the add-on effect of valsartan, an Angiotensin-Receptor Blocker, on top of the conventional treatment in high risk patients in Japan with hypertension in terms of the morbidity and mortality.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 9 December 2012.

1 Jan 2004 6 Sep 2005 1 Jan 2009 1 Jan 2009 1 Dec 2012 5 Jul 2011
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Diagnostic
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


Not available